Trulieve Cannabis (STU:T0A) Cyclically Adjusted Revenue per Share: €0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:T0A Trulieve Cannabis Corp STU:T0A
68 GF Score
Price €7.43
GF Value €4.83
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Trulieve Cannabis Cyclically Adjusted Revenue per Share?

Trulieve Cannabis STU:T0A -3.88% 68 Cyclically Adjusted Revenue per Share is €0.00 as of Jun. 2026. GuruFocus rates STU:T0A with a GF Score™ of 68/100 and a GF Value™ of €4.83 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Trulieve Cannabis's adjusted revenue per share for the three months ended in Jun. 2026 was €1.220. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.00 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-10), Trulieve Cannabis's current stock price is €7.43. Trulieve Cannabis's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €0.00. Trulieve Cannabis's Cyclically Adjusted PS Ratio of today is .

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Trulieve Cannabis was 1.63. The lowest was 0.98. And the median was 1.23.


Trulieve Cannabis  (STU:T0A) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Trulieve Cannabis was 1.63. The lowest was 0.98. And the median was 1.23.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Trulieve Cannabis Cyclically Adjusted Revenue per Share Related Terms


Trulieve Cannabis Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Trulieve Cannabis's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trulieve Cannabis Cyclically Adjusted Revenue per Share Chart

Trulieve Cannabis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 4.12

Trulieve Cannabis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 4.12 0.00 0.00

STU:T0A vs ANIP, XERS, HROW: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trulieve Cannabis Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Trulieve Cannabis's Cyclically Adjusted PS Ratio falls into.


STU:T0A
68GF Score
Trulieve Cannabis Corp STU:T0A
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trulieve Cannabis Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Trulieve Cannabis's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.22/333.9520*333.9520
=1.220

Current CPI (Jun. 2026) = 333.9520.

Trulieve Cannabis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 0.000 246.524 0.000
201803 0.000 249.554 0.000
201806 0.000 251.989 0.000
201809 0.243 252.439 0.321
201812 0.276 251.233 0.367
201903 0.340 254.202 0.447
201906 0.443 256.143 0.578
201909 0.583 256.759 0.758
201912 0.548 256.974 0.712
202003 0.754 258.115 0.976
202006 0.930 257.797 1.205
202009 0.981 260.280 1.259
202012 1.105 260.474 1.417
202103 1.276 264.877 1.609
202106 1.342 271.696 1.650
202109 1.391 274.310 1.693
202112 1.362 278.802 1.631
202203 1.542 287.504 1.791
202206 1.586 296.311 1.787
202209 1.582 296.808 1.780
202212 1.488 296.797 1.674
202303 1.410 301.836 1.560
202306 1.376 305.109 1.506
202309 1.365 307.789 1.481
202312 1.392 306.746 1.515
202403 1.445 312.332 1.545
202406 1.481 314.175 1.574
202409 1.347 315.301 1.427
202412 1.514 315.605 1.602
202503 1.441 319.799 1.505
202506 1.370 322.561 1.418
202509 1.284 324.800 1.320
202512 1.306 324.054 1.346
202603 1.254 330.213 1.268
202606 1.220 333.952 1.220

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.00 mean?
Trulieve Cannabis (STU:T0A) has a Cyclically Adjusted Revenue per Share of €0.00 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Trulieve Cannabis and its competitors.
Is Trulieve Cannabis' Cyclically Adjusted Revenue per Share too high?
Trulieve Cannabis' current Cyclically Adjusted Revenue per Share is €0.00. Overall, Trulieve Cannabis has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Cyclically Adjusted Revenue per Share compare to ANIP and XERS?
Trulieve Cannabis' Cyclically Adjusted Revenue per Share of €0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Trulieve Cannabis and its competitors. Trulieve Cannabis's current Cyclically Adjusted Revenue per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (STU:T0A) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.83, compared to a current price of €7.43 — trading 53.8% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.00. Trulieve Cannabis' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Trulieve Cannabis (STU:T0A), the current Cyclically Adjusted Revenue per Share is €0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trulieve Cannabis (STU:T0A) Overvalued in 2026?

Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued. The current stock price of €7.43 is trading 53.8% above its estimated GF Value™ of €4.83. GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.

Key valuation signals for STU:T0A:

  • Cyclically Adjusted Revenue per Share: €0.00
  • GF Value™: €4.83 vs. price of €7.43 (53.8% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the STU:T0A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Trulieve Cannabis Business Description

Other Exchanges TRLV:USATRUL:Canada
Address 3494 Martin Hurst Road, Tallahassee, FL, USA, 32312
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
68GF Score

Get the complete analysis for STU:T0A

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.43
Price
€4.83
GF Value